Market for atherectomy devices to intensify on a holistic note

The Atherectomy Devices Market will attend a 11.4% CAGR by reaching US $ 1,546.1 million of 2026. New electronic healthcare technologies such as 3D printing, GPS tracking, and portable biometric devices are being tested for clinical use. Cutting-edge technology is expected to be one of the driving forces of the healthcare industry over the next decade.

Atherectomy is a primary surgical technique used to increase lumen diameter gain. The procedure involves an ablation technique in the form of directional excision, rotational plaque ablation, as well as orbital and laser ablation.

However, it contributes only a limited part in all vascular intervention procedures. The atherectomy procedure involves the removal of the walls calcified by the plaque without causing vascular rupture or damage to the arteries. The prevalence of peripheral artery disease (PAD) and coronary heart disease (CAD) is high.

Planning for the future? Get access to a sample report on the Atherectomy Devices Market!

Company Profiles

  • Medtronic Plc.
  • Boston Scientific Society
  • Cardiovascular Systems, Inc.
  • Avinger, Inc.
  • Koninklijke Philips NV (Spectranetics + Volcano)
  • Others.

The growing demand for intervention with atherectomy centers on the greater shift towards advanced atherectomy devices used in the treatment of calcified arteries to reduce the risk of critical limb ischemia. Growing demand for interventional devices to achieve substantial lumen is expected to create demand for peripheral vascular devices and fuel the growth of the atherectomy devices market.

According to the latest research from the company, the global atherectomy devices market should be more than US $ 1,546.1 million, in value, by the end of 2026. Further, the Atherectomy Devices Market report predicts substantial growth potential with 11.4% CAGR through 2026.

According to data from the Center for Disease Control (CDC), the number of new cases per year of peripheral artery disease (PAD) was around 18 million in the United States alone. Of which, approximately 20.1% of patients with multiple calcified arteries require immediate attention.

The increasing incidence of peripheral artery disease is expected to increase the demand for interventional procedures, subsequently increasing the demand for atherectomy devices. The wide availability of atherectomy devices in the United States is fueling demand in North America.

How about revitalizing the strategy driven funnel to stay ahead in the atherectomy device market?

Peripheral interventional devices have transformed the way interventional surgeries are performed. Rapid advances in new technologies have transformed vascular intervention and associated devices. Modern atherectomy devices use advanced technologies that maximize productivity and efficiency. Advances in atherectomy heads have streamlined the concept of minimally invasive procedures.

Ultra-precision in making cuts and ablations through the use of diamond crowns and ablation heads leads to minimal vascular damage. These results have been supported by various ongoing studies, such as orbit ll and ECLIPS. This factor should again remove barriers to entry into the atherectomy device market. Rapid advancements in efficacy studies are fueling the growth of the atherectomy devices market.

New imaging techniques, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), can accurately determine the location of superficial and deep arteries and the degree of calcification. Using angiography, calcification can also be estimated by integrating the radiopacifications observed during cine-angiography.

The calcification observed on the internal surfaces of the arterial wall without a heart wave and before injection of contrast product denotes the severe level of calcification. Rotational atherectomy is an essential tool in the treatment of these severe calcifications.

The use of new advanced imaging techniques that eliminate harmful radiation imaging is expected to increase acceptance among end users, which in turn is expected to drive the market for atherectomy devices. Encouraging new statistics from Drug Coated Balloon (DCB) studies have restored interest in atherectomy ablation devices and several ongoing randomized clinical trials are currently evaluating ways to combine atherectomy and balloons. drug coatings (DCB).

The requirement for additional equipment in the operation of the rotational atherectomy device increases the costs of the procedure. The development of unreliable single-use devices provides leverage to current atherectomy devices and subsequently drives the market for atherectomy devices.

Thinking of introducing an offbeat product / technology to the atherectomy device market? Go to “Buy Now” for our Atherectomy Devices Market Report!

Atherectomy Devices Market: Segment Analysis and Forecast

PMR has segmented the global atherectomy devices market on the basis of device type into rotational atherectomy (RA) devices, directional atherectomy (DA) devices, orbital atherectomy (OA) devices, and atherectomy devices by laser ablation (LA). On the basis of end user, the market is further segmented into hospitals, outpatient surgical centers and office laboratories (OBLs).

In terms of revenue, the Rotational Atherectomy (RA) Devices segment in the Atherectomy Devices market is expected to hold a significant share during the forecast period. According to PMR, the rotational atherectomy (RA) device segment accounted for over 31.7% revenue share in the overall atherectomy device market in 2017.

However, the increasing adaptation of orbital atherectomy (OA) devices in coronary and peripheral procedures due to benefits such as reduced risk of vascular puncture and technological advancements, is expected to fuel segment growth in the near future. .

However, the Laser Ablation Atherectomy Devices segment in the Atherectomy Devices market is expected to present limited investment opportunities, in terms of revenue, throughout the forecast period.

The company has segmented the global atherectomy device market on the basis of device type, indication, and end users. In terms of revenue, the Peripheral Artery Disease Indication Type segment in the Atherectomy Devices market is expected to hold a significant share during the forecast period. The Peripheral Artery Disease Indication Type segment in the Atherectomy Devices market is expected to present limited investment opportunities, in terms of revenue, throughout the forecast period.

About Us :-

Persistence Market Research is here to provide businesses with a one stop solution to improve customer experience. It is committed to gathering the appropriate feedback after going through personalized interactions with customers to add value to the customer experience by acting as the “missing” link between “customer relationships” and “business results”. “. The best possible returns are guaranteed there.

Contact us:

Persistence market research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
US Phone – + 1-646-568-7751
United States-Canada Toll Free – +1 800-961-0353
Sales[email protected]
Website –

Previous Spatial 3D printing and nanostructures: how Goodman Technologies is pioneering new space technologies -
Next 45 Years of Printmaking Exhibition at the Tairawhiti Museum - The Gisborne Herald

No Comment

Leave a reply

Your email address will not be published.